Document is current
Any future updates will be listed below
-
Authors
Van Gerwen, Olivia T. https://orcid.org/0000-0002-9362-6234
Muzny, Christina A. https://orcid.org/0000-0002-4005-3858
Marrazzo, Jeanne M.
-
Funding
Funding for this research was provided by:
Doris Duke Charitable Foundation (Grant #2021255)
- License Information
-
More Information
Article History
Received: 21 October 2021
Accepted: 20 June 2022
First Online: 2 August 2022
Competing interests
: O.T.V.G. has received research grant support from Gilead Sciences, Inc. and Abbott Molecular, and serves on the scientific advisory board for Scynexis. C.A.M. has received research grant support from Lupin Pharmaceuticals, Gilead Sciences, Inc. and Abbott Molecular, is a consultant for Cepheid, Scynexis, Lupin Pharmaceuticals, PhagoMed and BioFire Diagnostics, and has received honoraria from Elsevier, Abbott Molecular, Cepheid, Becton Dickinson, Roche Diagnostics and Lupin. J.M. serves on scientific advisory committees for Merck and Gilead, has received research grant support from Becton Dickinson and GlaxoSmithKline, and serves as a scientific advisor for OSEL.
